Postdoctoral Fellow
Pfizer Inc.
Kari Martyniak, PhD, is a postdoctoral fellow at Pfizer. Her post-doctoral project, focuses on establishing key cellular processes underlying species differences in LNP therapies. This is a collaborative effort of the Biomarkers & Biomeasures and Translational Modeling Teams at Pfizer. This project involves establishing relevent primary cellular systems, developing cell based assays, and utilizing flow cytometry, proteomics and modeling approaches.
Kari completed her Ph.D. in Biomedical Sciences in December 2022 at the University of Central Florida. In her graduate work Kari designed cell based assays for characterization of complex in vitro model systems in combination with tissue engineering approaches.